Freezing away AF: new study tracks 3-Year success of cryoablation

NCT ID NCT05227053

First seen Jun 26, 2026 · Last updated Jul 23, 2026 · Updated 3 times

Summary

This study follows 200 people with paroxysmal atrial fibrillation (AF) who undergo a procedure using a freezing catheter to isolate the pulmonary veins. The goal is to see how many remain free from AF, atrial flutter, or atrial tachycardia for up to 3 years, and to track safety events over 12 months. It is an observational, post-approval study, meaning the device is already approved and in use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Arctic Front™ cardiac cryoablation catheter (a device that freezes heart tissue to stop abnormal electrical signals)
What this could lead to
If successful, this could confirm that cryoablation is a safe and effective long-term option for controlling paroxysmal atrial fibrillation.
What could go wrong
This is an observational study, not a randomized trial, so results may be less definitive. Risks include rare but serious complications like heart damage or stroke from the procedure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PAROXYSMAL ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Alaska Heart Institute

    ACTIVE_NOT_RECRUITING

    Anchorage, Alaska, 99508, United States

  • BayCare Medical Group Cardiology

    RECRUITING

    Clearwater, Florida, 33756, United States

  • Cardiology Associates of Fairfield County

    RECRUITING

    Stamford, Connecticut, 06905-5522, United States

  • Heart Rhythm Solutions

    RECRUITING

    Davie, Florida, 33328, United States

  • Henry Ford Heart & Vascular

    RECRUITING

    Detroit, Michigan, 48202-2608, United States

  • Iowa Heart

    RECRUITING

    West Des Moines, Iowa, 50266, United States

  • MedStar Washington Hospital Center

    RECRUITING

    Washington D.C., District of Columbia, 20010, United States

  • Our Lady of the Lake

    WITHDRAWN

    Baton Rouge, Louisiana, 70808, United States

  • Southcoast Health System

    RECRUITING

    North Dartmouth, Massachusetts, 02747, United States

  • Stern Cardiovascular Foundation

    RECRUITING

    Germantown, Tennessee, 38138, United States

  • Texas Health Research and Education Institute

    RECRUITING

    Dallas, Texas, 75231, United States

  • The Lindner Research Center

    RECRUITING

    Cincinnati, Ohio, 45219, United States

  • University of Tennessee Methodist Physicians

    WITHDRAWN

    Memphis, Tennessee, 38104-6638, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.